These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 22890603)
1. Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger. Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y Breast Cancer; 2014 May; 21(3):292-301. PubMed ID: 22890603 [TBL] [Abstract][Full Text] [Related]
2. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy. Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y Int J Clin Oncol; 2013 Feb; 18(1):54-61. PubMed ID: 22068463 [TBL] [Abstract][Full Text] [Related]
3. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335 [TBL] [Abstract][Full Text] [Related]
4. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289 [TBL] [Abstract][Full Text] [Related]
5. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy. Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546 [TBL] [Abstract][Full Text] [Related]
6. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size. Fodor J; Polgár C; Major T; Németh G Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264 [TBL] [Abstract][Full Text] [Related]
7. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era. Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of molecular subtypes, ki67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy. Selz J; Stevens D; Jouanneau L; Labib A; Le Scodan R Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1123-32. PubMed ID: 22572073 [TBL] [Abstract][Full Text] [Related]
9. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Truong PT; Woodward WA; Thames HD; Ragaz J; Olivotto IA; Buchholz TA Int J Radiat Oncol Biol Phys; 2007 May; 68(1):59-65. PubMed ID: 17321065 [TBL] [Abstract][Full Text] [Related]
10. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436 [TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825 [TBL] [Abstract][Full Text] [Related]
12. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes. He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605 [TBL] [Abstract][Full Text] [Related]
13. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Jagsi R; Raad RA; Goldberg S; Sullivan T; Michaelson J; Powell SN; Taghian AG Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1035-9. PubMed ID: 15990006 [TBL] [Abstract][Full Text] [Related]
14. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy. Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896 [TBL] [Abstract][Full Text] [Related]
15. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091 [TBL] [Abstract][Full Text] [Related]
16. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection. Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456 [TBL] [Abstract][Full Text] [Related]
17. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status. Yang PS; Chen CM; Liu MC; Jian JM; Horng CF; Liu MJ; Yu BL; Lee MY; Chi CW Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):516-22. PubMed ID: 19577858 [TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. Le Scodan R; Selz J; Stevens D; Bollet MA; de la Lande B; Daveau C; Lerebours F; Labib A; Bruant S Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e1-7. PubMed ID: 21377284 [TBL] [Abstract][Full Text] [Related]
19. Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes. Matsunuma R; Oguchi M; Fujikane T; Matsuura M; Sakai T; Kimura K; Morizono H; Iijima K; Izumori A; Miyagi Y; Nishimura S; Makita M; Gomi N; Horii R; Akiyama F; Iwase T Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):845-52. PubMed ID: 22138460 [TBL] [Abstract][Full Text] [Related]
20. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence? Mamtani A; Patil S; Stempel MM; Morrow M Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]